Canadian Myeloma Research Group

The Canadian Myeloma Research Group (CMRG) is a non-profit academic research organization that serves as the clinical trial arm for the Canadian myeloma community. It coordinates a network of over 30 academic centers across Canada to conduct investigator-initiated clinical trials and real-world evidence studies. CMRG is best known for managing the Canadian Multiple Myeloma Database, which tracks longitudinal data for thousands of patients to improve treatment outcomes. The organization collaborates extensively with global pharmaceutical companies to bring innovative therapies, such as CAR-T cells and bispecific antibodies, to Canadian patients. Through its rigorous research framework, CMRG plays a pivotal role in defining the standard of care for myeloma both nationally and internationally.